"Targeted" therapies for non-small cell lung cancer

Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.

Circulation·2026

Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

The Impact of Immunotherapy on Incidence of Second Primary Malignancies: A Surrogate for Antitumor Surveillance Activation.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Long-term outcomes of Extensive-Stage small cell lung cancer treated with chemotherapy or Chemo-immunotherapy: A propensity score adjusted cohort study.

Lung cancer (Amsterdam, Netherlands)·2025

Neutrophil to lymphocyte ratio varies in magnitude and biomarker utility based on patient demographics.

The Journal of clinical investigation·2025

A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumors.

BJC reports·2025

Integrated Genomic and Immune Profiling of Early Onset Lung Cancer in East Asians Reveals a Distinct Molecular Architecture.

Clinical lung cancer·2026

Spatially Fractionated Induction Radiotherapy to Widen the Therapeutic Window in Locally Advanced Non-Small-Cell Lung Cancer (SPARROW): Study Protocol of a Multicenter, Randomized, Open-Label Seamless Phase I/II Trial.

Clinical lung cancer·2026

Clinical Efficacy and Safety of Icotinib as Adjuvant Therapy for Resected Stage IA Lung Adenocarcinoma: A Real-world Study.

Clinical lung cancer·2026

Brief Report on Sociodemographic Patterns of Lung Cancer in Individuals Who Never Smoked.

Clinical lung cancer·2026

Incidence of Radiation Pneumonitis Following EGFR-TKI Combined With Thoracic Radiotherapy in Unresectable Stage III or IV Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis.

Clinical lung cancer·2026

Trends in Surgical Management of Early-stage Small Cell Lung Cancer.

Clinical lung cancer·2026

Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Outcomes of target therapies for pediatric BRAF V600-mutant low-grade gliomas: A systematic review and meta-analysis.

Neuro-oncology advances·2026

Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression.

PeerJ·2026

Titanium dioxide nanoparticle-modified screen-printed electrode for erlotinib determination.

ADMET & DMPK·2026

Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

MedComm·2026

Recurrence distance analysis for clinical target volume optimization in glioblastoma.

Clinical and translational radiation oncology·2026

Related Experiment Videos

"Targeted" therapies for non-small cell lung cancer

Related Concept Videos

Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.

Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.

The Impact of Immunotherapy on Incidence of Second Primary Malignancies: A Surrogate for Antitumor Surveillance Activation.

Long-term outcomes of Extensive-Stage small cell lung cancer treated with chemotherapy or Chemo-immunotherapy: A propensity score adjusted cohort study.

Neutrophil to lymphocyte ratio varies in magnitude and biomarker utility based on patient demographics.

A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumors.

Integrated Genomic and Immune Profiling of Early Onset Lung Cancer in East Asians Reveals a Distinct Molecular Architecture.

Spatially Fractionated Induction Radiotherapy to Widen the Therapeutic Window in Locally Advanced Non-Small-Cell Lung Cancer (SPARROW): Study Protocol of a Multicenter, Randomized, Open-Label Seamless Phase I/II Trial.

Clinical Efficacy and Safety of Icotinib as Adjuvant Therapy for Resected Stage IA Lung Adenocarcinoma: A Real-world Study.

Brief Report on Sociodemographic Patterns of Lung Cancer in Individuals Who Never Smoked.

Incidence of Radiation Pneumonitis Following EGFR-TKI Combined With Thoracic Radiotherapy in Unresectable Stage III or IV Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis.

Trends in Surgical Management of Early-stage Small Cell Lung Cancer.

Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.

Outcomes of target therapies for pediatric BRAF V600-mutant low-grade gliomas: A systematic review and meta-analysis.

Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression.

Titanium dioxide nanoparticle-modified screen-printed electrode for erlotinib determination.

Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

Recurrence distance analysis for clinical target volume optimization in glioblastoma.

Related Experiment Videos

"Targeted" therapies for non-small cell lung cancer

Related Concept Videos

Related Articles